VOYA Investment Management
CASI

VOYA Investment Management’s CASI Pharmaceuticals CASI Stock Holding History

VOYA Investment Management’s Portfolio CASI Stock Details CASI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,168
Closed -$76K – 2823
2021
Q1 		$76K Sell
3,168
-109
-3% -$3.06K ﹤0.01% 2705
2020
Q4 		$97K Buy
3,277
+1,176
+56% +$25.6K ﹤0.01% 2566
2020
Q3 		$32K Hold
2,101
– – ﹤0.01% 2474
2020
Q2 		$53K Sell
2,101
-898
-30% -$19.5K ﹤0.01% 2443
2020
Q1 		$61K Hold
2,999
– – ﹤0.01% 2456
2019
Q4 		$93K Buy
2,999
+810
+37% +$26.3K ﹤0.01% 2565
2019
Q3 		$73K Hold
2,189
– – ﹤0.01% 2461
2019
Q2 		$70K Hold
2,189
– – ﹤0.01% 2523
2019
Q1 		$63K Hold
2,189
– – ﹤0.01% 2496
2018
Q4 		$88K Buy
2,189
+252
+13% +$9.54K ﹤0.01% 2426
2018
Q3 		$90K Hold
1,937
– – ﹤0.01% 2513
2018
Q2 		$159K Buy
+1,937
New +$131K ﹤0.01% 2425

Other funds holding CASI

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
IACGFIA
IDG-Accel China Growth Fund III Associates Hong Kong $31.2M AUM 2.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WSCM
Wellington Shields Capital Management New York $666M AUM 45.43% 1-Year Est. Return
WSC
Wellington Shields & Co New York $392M AUM 30.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

VOYA Investment Management's CASI Position: Q2 2021 in Review

VOYA Investment Management sold out of CASI Pharmaceuticals (CASI) in Q2 2021, closing a stake of 3,168 shares — an estimated $76K sold.

VOYA Investment Management first reported a position in CASI in Q2 2018 and held it in 12 quarters. The position peaked at $159K in Q2 2018. 68 funds tracked by Wall St. Rank hold CASI as of Q2 2021.

  • VOYA Investment Management reported no remaining CASI Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • VOYA Investment Management sold 3,168 CASI Pharmaceuticals shares in Q2 2021, an estimated $76K.
  • VOYA Investment Management first reported a position in CASI Pharmaceuticals in Q2 2018 and held it in 12 quarters.
  • VOYA Investment Management's CASI Pharmaceuticals position peaked at $159K in Q2 2018.
  • 68 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q2 2021.

Based on VOYA Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.